相似文献
1
Mechanism-based inactivator of isocitrate lyases 1 and 2 from .
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7617-7622. doi: 10.1073/pnas.1706134114. Epub 2017 Jul 5.
2
Mechanism-Based Inactivation of Isocitrate Lyase 1 by (2,3)-2-Hydroxy-3-(nitromethyl)succinic acid.
J Am Chem Soc. 2021 Oct 27;143(42):17666-17676. doi: 10.1021/jacs.1c07970. Epub 2021 Oct 19.
3
Covalent Inactivation of Isocitrate Lyase by -2,3-Epoxy-Succinic Acid.
ACS Chem Biol. 2021 Mar 19;16(3):463-470. doi: 10.1021/acschembio.0c00740. Epub 2021 Mar 10.
4
Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Biochemistry. 2013 Dec 23;52(51):9286-93. doi: 10.1021/bi4013319. Epub 2013 Nov 26.
5
Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
PLoS One. 2021 May 5;16(5):e0251067. doi: 10.1371/journal.pone.0251067. eCollection 2021.
6
Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
Nat Struct Biol. 2000 Aug;7(8):663-8. doi: 10.1038/77964.
7
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
Sci Rep. 2020 Nov 3;10(1):18925. doi: 10.1038/s41598-020-75799-8.
8
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6.
9
The Nitro Group as a Masked Electrophile in Covalent Enzyme Inhibition.
ACS Chem Biol. 2018 Jun 15;13(6):1470-1473. doi: 10.1021/acschembio.8b00225. Epub 2018 May 23.
10
Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
Int J Biol Macromol. 2019 Dec 1;141:927-936. doi: 10.1016/j.ijbiomac.2019.09.038. Epub 2019 Sep 7.
引用本文的文献
1
demonstration and characterization of a condensed, reverse TCA (crTCA) cycle.
Front Plant Sci. 2025 Jun 9;16:1556957. doi: 10.3389/fpls.2025.1556957. eCollection 2025.
2
Structure and catalytic mechanism of methylisocitrate lyase, a potential drug target against Coxiella burnetii.
J Biol Chem. 2025 Apr 16;301(6):108517. doi: 10.1016/j.jbc.2025.108517.
3
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.
Sci Rep. 2024 May 13;14(1):10904. doi: 10.1038/s41598-024-61752-6.
4
Design, Synthesis, and Mechanistic Studies of ()-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase.
ACS Chem Biol. 2024 May 17;19(5):1066-1081. doi: 10.1021/acschembio.4c00022. Epub 2024 Apr 17.
5
Study of peripheral domains in structure-function of isocitrate lyase (ICL) from Pseudomonas aeruginosa.
World J Microbiol Biotechnol. 2023 Oct 12;39(12):339. doi: 10.1007/s11274-023-03768-0.
6
Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study.
Mol Divers. 2024 Oct;28(5):2783-2799. doi: 10.1007/s11030-023-10711-w. Epub 2023 Aug 14.
7
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.
Mol Biomed. 2022 Dec 22;3(1):48. doi: 10.1186/s43556-022-00106-y.
8
Mycobacterium tuberculosis whiB3 and Lipid Metabolism Genes Are Regulated by Host Induced Oxidative Stress.
Microorganisms. 2022 Sep 11;10(9):1821. doi: 10.3390/microorganisms10091821.
9
Targeting Non-Replicating and Latent Infection: Alternatives and Perspectives (Mini-Review).
Int J Mol Sci. 2021 Dec 10;22(24):13317. doi: 10.3390/ijms222413317.
10
Insights into the molecular determinants involved in persistence and their therapeutic implications.
Virulence. 2021 Dec;12(1):2721-2749. doi: 10.1080/21505594.2021.1990660.
本文引用的文献
1
Prolonged and tunable residence time using reversible covalent kinase inhibitors.
Nat Chem Biol. 2015 Jul;11(7):525-31. doi: 10.1038/nchembio.1817. Epub 2015 May 25.
2
Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids.
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4976-81. doi: 10.1073/pnas.1400390111. Epub 2014 Mar 17.
3
Cysteine is the general base that serves in catalysis by isocitrate lyase and in mechanism-based inhibition by 3-nitropropionate.
Biochemistry. 2014 Jan 14;53(1):178-87. doi: 10.1021/bi401432t. Epub 2013 Dec 24.
4
Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Biochemistry. 2013 Dec 23;52(51):9286-93. doi: 10.1021/bi4013319. Epub 2013 Nov 26.
5
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
J Am Chem Soc. 2012 Jan 18;134(2):912-5. doi: 10.1021/ja211042r. Epub 2011 Dec 21.
6
The resurgence of covalent drugs.
Nat Rev Drug Discov. 2011 Apr;10(4):307-17. doi: 10.1038/nrd3410.
7
Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis.
Microbiology (Reading). 2009 Oct;155(Pt 10):3166-3175. doi: 10.1099/mic.0.030858-0. Epub 2009 Aug 14.
8
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334.
9
Evolution of glyoxylate cycle enzymes in Metazoa: evidence of multiple horizontal transfer events and pseudogene formation.
Biol Direct. 2006 Oct 23;1:31. doi: 10.1186/1745-6150-1-31.
10
Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.
Mol Microbiol. 2006 Aug;61(4):940-7. doi: 10.1111/j.1365-2958.2006.05297.x.
Zotero 插件